SCHEMBL29399820

SCHEMBL29399820

CC(C)C1=CCC2=C(CC[C@H]3C(C)(C)CCC[C@]23C)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.43
▸ USP2 O75604 3/20 0.43
▸ TP53 P04637 3/20 0.43
▸ MAPT P10636 3/20 0.43
▸ CYP19A1 P11511 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ HSP90AA1 P07900 1/20 0.43
▸ ALOX15 P16050 1/20 0.38
▸ FDPS P14324 7/20 0.38
▸ BCL9 O00512 3/20 0.35
▸ CTNNB1 P35222 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ PTGES O14684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ PNLIP P16233 1/20 0.35
▸ ALOX12 P18054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31255972 1.00 CYP3A4 (0.43) CYP3A4USP2TP53MAPTCYP19A1
SCHEMBL9471626 0.83 KARS1 (0.50) CYP3A4MAPTKDM4EALOX15ALDH1A1
SCHEMBL21683296 0.74 CYP3A4 (0.48) CYP3A4USP2TP53MAPTCYP19A1
SCHEMBL11069779 0.72 CYP19A1 (0.47) CYP3A4USP2TP53MAPTCYP19A1
SCHEMBL29771442 0.64 ALOX15 (0.39) CYP3A4USP2TP53MAPTCYP19A1
SCHEMBL30482554 0.64 CYP3A4 (0.62) CYP3A4USP2TP53MAPTCYP19A1
SCHEMBL32659910 0.63 FDPS (0.70) CYP3A4USP2TP53MAPTCYP19A1
Ferruginol SCHEMBL13423521 0.62 KARS1 (0.73) CYP3A4USP2TP53MAPTCYP19A1
Sempervirol SCHEMBL10524413 0.62 KARS1 (0.66) CYP3A4USP2TP53MAPTCYP19A1
Sempervirol SCHEMBL10524412 0.62 KARS1 (0.66) CYP3A4USP2TP53MAPTCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263763-A1 PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS UNIVERSITY OF COPENHAGEN (DK) 2025-08-21 — — US claimed
EP-4204576-A1 PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS Københavns Universitet (DK) 2023-07-05 — — EP claimed
WO-2022043461-A1 PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS Københavns Universitet (DK) 2022-03-03 — — WO claimed
US-20250346933-A1 FUNGAL CELLS FOR PRODUCTION OF FATTY ACIDS AND FATTY ACID-DERIVED PRODUCTS MELT&MARBLE AB (SE) 2025-11-13 — — US disclosed
US-12398409-B2 Yeast cells genetically modified for downregulation of pyruvate decarboxylase activity and FBP-sensitive pyruvate kinase MELT&MARBLE AB (SE) 2025-08-26 — — US disclosed
US-20250263763-A1 PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS UNIVERSITY OF COPENHAGEN (DK) 2025-08-21 — — US disclosed
CN-116103176-B Saccharomyces cerevisiae strain for producing phytosphingosine 浙江工业大学 2025-05-13 — — CN disclosed
CN-119931857-A Compound red sage root bionic synthetic engineering bacterium and application thereof 中国科学院天津工业生物技术研究所 2025-05-06 — — CN disclosed
US-20250137015-A1 YEAST PLATFORM FOR RENEWABLE INDUSTRIAL TERPENE PRODUCTION Wang, Zhen (US) 2025-05-01 — — US disclosed
CN-119265151-A (+) -Germacrene A high-yield gene element, genetically engineered bacterium and application thereof 杭州师范大学 2025-01-07 — — CN disclosed
CN-118530864-A Recombinant yeast engineering bacteria for producing tripterygium Abietatrien-14-ol 西北农林科技大学 2024-08-23 — — CN disclosed
US-20220372526-A1 METHOD FOR PRODUCTION OF NOVEL DITERPENE SCAFFOLDS UNITED STATES DEPARTMENT OF ENERGY 2022-11-24 — — US disclosed
EP-4054542-A1 BIOSYNTHESIS OF CHEMICALLY DIVERSIFIED NON-NATURAL TERPENE PRODUCTS Board Of Trustees Of Michigan State University (US) 2022-09-14 — — EP disclosed
CN-111548401-B Salvia miltiorrhiza ERF-VII transcription factor SmERF73 and application thereof 中国中医科学院中药研究所 2022-08-02 — — CN disclosed
CN-114480312-A C-14 hydroxylase of abietane type tricyclic diterpenoid compound 首都医科大学附属北京世纪坛医院 2022-05-13 — — CN disclosed
CN-114410495-A Recombinant yeast engineering bacterium for high-yield friedelin 首都医科大学 2022-04-29 — — CN disclosed
CN-114410726-A C-14 and C-12 hydroxylase of tricyclic diterpene compounds 首都医科大学附属北京世纪坛医院 2022-04-29 — — CN disclosed
CN-108271383-B Fungal cells and methods for producing very long chain fatty acid derivatives 梅特玛博有限公司 2022-04-19 — — CN disclosed
EP-3963067-A1 GLUCONATE DEHYDRATASE ENZYMES AND RECOMBINANT CELLS BP Corporation North America Inc. (US) 2022-03-09 — — EP disclosed
WO-2022043461-A1 PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS Københavns Universitet (DK) 2022-03-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250263763-A1 PRODUCTION OF OXYGENATED DITERPENOID COMPOUNDS POR, CYP11B1, CYP11B2 CYP3A4 8/4885USP2 2135/4885TP53 3418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback